# FDA Inspection 1020675 - American National Red Cross - July 24, 2017

Source: https://www.keypedia.com/records/fda_inspections/american-national-red-cross/6dcfb6b5-bccd-4039-8da0-577e55a90bae
Source feed: FDA_Inspections

> FDA Inspection 1020675 for American National Red Cross on July 24, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1020675
- Company Name: American National Red Cross
- Inspection Date: 2017-07-24
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 909624 - 2014-12-16](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/46da9e0a-5ff0-444e-bc1e-3ae6c35a9fec)
- [FDA Inspection 854464 - 2013-11-01](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/b366e61b-2f3f-4c58-a913-f16e543ece20)
- [FDA Inspection 751382 - 2011-10-25](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/4851db70-1d87-47dc-b0df-148568a2b059)
- [FDA Inspection 624548 - 2009-10-20](https://www.keypedia.com/records/fda_inspections/american-national-red-cross/33b0ab08-4066-44b7-8956-b1958696750d)

Company: https://www.keypedia.com/companies/american-national-red-cross/246ce03d-6142-4412-a12a-f311e2ac602d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d